Evidence Report/Technology Assessment Number 78

Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer

File Inventory


Prepared by:

Southern California-RAND Evidence-based Practice Center
Santa Monica, CA

EPC Director
   Paul Shekelle, M.D., Ph.D.
Principal Investigators
   Ian Coulter, Ph.D.
   Mary Hardy, M.D.
EPC Director/Statistician
   Sally C. Morton, Ph.D.
Expert Reviewers
   Joya T. Favreau, M.D.
   James Gagne, M.D.
   S. Adelaide Coulter, R.N.
   Jay Udani, M.D.
   Elizabeth A. Roth, M.A.
   Lara K. Jungvig, B.A.
   Sydne Newberry, Ph.D.
   Leigh Rohr
   Louis R. Ramirez, B.A.


File Name	Description			Software	Version		File	Size
________________________________________________________________________________________________
01front.doc	Microsoft Word® Document	MS Word®	2002		81KB	9 pages
Contents: Title Page, Acknowledgments, Preface, Structured Abstract, Table of Contents
________________________________________________________________________________________________
02summ.doc	Microsoft Word® Document	MS Word®	2002		69KB	3 pages
Contents: Summary: Overview, Methodology, Findings, Conclusions, Future Research
________________________________________________________________________________________________
03chap1.doc	Microsoft Word® Document	MS Word®	2002		69KB	5 pages
Contents: Chapter 1. Introduction: Purpose, Specific Aims, A Brief Review of the Use of CAM 
for Cancer Treatment
________________________________________________________________________________________________
04chap2.doc	Microsoft Word® Document	MS Word®	2002		102KB	11 pages
Contents: Chapter 2. Methodology: Summary; A Best-Case Series; Study Design; Figure 1. Research 
Sequence and Tasks; Development of the Instruments; Research Staff; Data Sensitivity; 
Clinic Visits
________________________________________________________________________________________________
05chap3.doc	Microsoft Word® Document	MS Word®	2002		1.1MB	81 pages
Contents: Chapter 3. Results: Overview of Case Review; Table 1. Status Report of Requested 
Materials (IAT); Table 2. Status Report of Requested Materials (Naltrexone); Cancer Best-Case 
Series Patient #1-1 Nodular Sclerosing Lymphoma Stage 1B; Cancer Best-Case Series Patient #1-3 
Squamous Cell Carcinoma of the Right Vocal Cord and Anterior Commissure; Cancer Best-Case Series 
Patient #1-4 Metastatic Non-Small Cell Carcinoma of the Lung; Cancer Best-Case Series Patient 
#1-6 Poorly Differentiated Nodular Lymphoma; Cancer Best-Case Series Patient #1-7 Peritoneal 
Mesothelioma; Cancer Best-Case Series Patient #1-9 Ovarian Cyst Adenocarcinoma; Cancer Best-Case 
Series Patient #1-11 Peritoneal Mesothelioma; Cancer Best-Case Series Patient #1-19 Sigmoid 
Carcinoma (Dukes Stage C2); Cancer Best-Case Series Patient #1-22 Squamous Cell Carcinoma of 
the Tongue; Cancer Best-Case Series Patient #2-10 Pancreatic Cancer Involving the Bile Duct; 
Cancer Best-Case Series Patient #2-21 Melanoma; Cancer Best-Case Series Patient #2-22 
Adenocarcinoma of the Endometrium With Extension into the Peritoneum
________________________________________________________________________________________________
06chap4.doc	Microsoft Word® Document	MS Word®	2002		59KB	2 pages
Contents: Chapter 4. Conclusions: Limitations of the Study
________________________________________________________________________________________________
07chap5.doc	Microsoft Word® Document	MS Word®	2002		54KB	1 page
Contents: Chapter 5: Future Research
________________________________________________________________________________________________
08refs.doc	Microsoft Word® Document	MS Word®	2002		69KB	2 pages
Contents: References
________________________________________________________________________________________________
09appa.doc	Microsoft Word® Document	MS Word®	2002		395KB	20 pages
Contents: Appendix A. CANCER-Best-Case Series Abstraction Form
________________________________________________________________________________________________
10appb.doc	Microsoft Word® Document	MS Word®	2002		25KB	4 pages
Contents: Appendix B. Case Report Form
________________________________________________________________________________________________
11appc.doc	Microsoft Word® Document	MS Word®	2002		406KB	73 pages
Contents: Appendix C. Patient Questionnaires
________________________________________________________________________________________________
12appd.doc	Microsoft Word® Document	MS Word®	2002		94KB	12 pages
Contents: Appendix D. Letter to Patients and Consent Forms
________________________________________________________________________________________________
13appe.doc	Microsoft Word® Document	MS Word®	2002		684KB	88 pages
Contents: Appendix E. Additional Cases Reviewed
________________________________________________________________________________________________

AHRQ Publication No. 03-E030
Current as of April 2003


Internet Citation:

Best-Case Series for the Use of Immuno-Augmentation Therapy and Naltrexone for the Treatment of Cancer. File Inventory, Evidence Report/Technology Assessment Number Number 78. AHRQ Publication No. 03-E030, April 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/imauginv.htm


Return to Evidence Report Files Download
Evidence-based Practice
AHRQ Home Page
Department of Health and Human Services